Cardinal Health officer plans $2.7M stock sale

Cardinal Health, Inc. (CAH) reports that company officer Michelle Greene has filed a notice of proposed sale of Cardinal Health common stock under Rule 144.

Rhea-AI Filing Summary

Cardinal Health, Inc. (CAH) reports that company officer Michelle Greene has filed a notice of proposed sale of Cardinal Health common stock under Rule 144. The filing lists 11,650 shares to be sold through Merrill from an account in Columbus, Ohio, with an aggregate market value of $2,746,148.42 as of the filing. The shares derive from equity awards scheduled to vest on August 15, 2026, including restricted stock and performance units. Cardinal Health common shares outstanding are stated as 232,575,728, a baseline figure, not the amount being sold. The expected sale date is listed as August 18, 2026 on the NYSE.

Key Figures

Shares to be sold: 11,650 shares Aggregate market value: $2,746,148.42 Shares outstanding: 232,575,728 shares +3 more

6 metrics

Shares to be sold 11,650 shares Proposed resale of Cardinal Health common stock under Rule 144

Aggregate market value $2,746,148.42 Value associated with the 11,650 shares covered by the notice

Shares outstanding 232,575,728 shares Cardinal Health common shares outstanding cited as a baseline figure

Restricted stock vesting shares 3,565 shares Common shares from a Restricted Stock Vest event on August 15, 2026

Performance units vesting shares 8,085 shares Common shares from a Performance Unit Vest event on August 15, 2026

Planned sale date 08/18/2026 Expected date for potential NYSE sale via Merrill

Key Terms

Rule 144, Restricted Stock Vest, Performance Unit Vest

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vest financial

"Common | 08/15/2026 | Restricted Stock Vest | Cardinal Health, Inc."

A restricted stock vest is the moment when shares granted to an employee or executive under conditions (like staying at the company or hitting targets) officially become theirs to keep or sell. Think of it as a timed gift that unlocks only after certain rules are met. Investors watch vesting because it can change who controls shares, create potential selling pressure when large blocks unlock, and reveal how management’s incentives are aligned with company performance.

Performance Unit Vest financial

"Common | 08/15/2026 | Performance Unit Vest | Cardinal Health, Inc."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for Cardinal Health (CAH)?

The Form 144 indicates that officer Michelle Greene has notified of a planned sale of 11,650 CAH shares under Rule 144. It is a regulatory notice of potential resale of restricted or control securities, not an executed trade confirmation.

How many Cardinal Health (CAH) shares are proposed to be sold and at what value?

The notice covers a proposed sale of 11,650 CAH common shares with an aggregate market value of $2,746,148.42. These figures reflect the amount and value referenced in the Rule 144 filing for potential resale.

When are the Cardinal Health (CAH) equity awards vesting for this Form 144?

The source shares come from awards vesting on August 15, 2026, including restricted stock and performance units. After vesting, up to 11,650 shares are noticed for potential sale under Rule 144 shortly thereafter.

What portion of Cardinal Health (CAH) shares does this Form 144 represent?

The filing cites 232,575,728 CAH shares outstanding and a proposed sale of 11,650 shares. The outstanding figure serves as overall share context, while only the 11,650 shares are referenced for potential resale in this notice.

Which broker and market are involved in the Cardinal Health (CAH) Form 144 sale?

The proposed transaction lists Merrill as the broker and references trading on the NYSE. The expected sale date in the notice is August 18, 2026, subject to Rule 144 conditions and market execution.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2026 - 04:46 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001945228
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Cardinal Health, Inc
SEC File Number	001-11373
Address of Issuer	7000 Cardinal Place Dublin OHIO 43017
Phone	614-757-5000
Name of Person for Whose Account the Securities are To Be Sold	Michelle Greene
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Dr 5th Flr Columbus OH 43240	11650	2746148.42	232575728	08/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2026	Restricted Stock Vest	Cardinal Health, Inc.			3565	08/15/2026	NA
Common	08/15/2026	Performance Unit Vest	Cardinal Health, Inc.			8085	08/15/2026	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Michelle Greene
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)